|Email Newsletters from Pharmaceutical Technology and Pharmaceutical Technology Europe|
Providing the latest business, scientific, and regulatory news for the pharmaceutical and biotech industries.
News from Europe's pharmaceutical manufacturing industry coupled with upcoming events, and exclusive articles and interviews from industry experts.
Fast Locator 2013-2014: Cambridge
Cambridge Major Laboratories, Inc.
CML’s reach is truly global. Operating three facilities in the United State and Europe, CML is organized by five key integrated Centers of Excellence; Process chemistry, API Manufacturing, Analytical Sciences, Solid State Chemistry and Quality Assurance.
Our philosophy revolves around R&D and a deep passion for chemistry. Nearly 50% of CML scientists hold a Ph.D. CML is well positioned to deliver on the most challenging and complex chemistry projects. Strong R&D to support early scale up during preclinical development ensures that your molecule will transition into first-in-human studies as smoothly as possible. CML has the resources to meet your entire clinical and commercial API needs, and we have developed and scaled-up literally hundreds of projects successfully.
Our passion, expertise, and communication fuel proactive solutions in every project. When you are looking for a trusted partner to help take your molecule from concept to clinic and beyond, look to CML.
Formulation Development & Phase I/II Clinical Trial Materials (CTM)
API and advanced intermediates (cGMP, small molecule) manufacturing capabilities